Anavex Life Sciences Corp.
Treatment of cardiac dysfunction

Last updated:

Abstract:

A method for treatment of cardiac dysfunction comprising administering to a subject in need thereof a therapeutically effective amount of at least one of ANAVEX 2-73 or ANAVEX 19-144 or pharmaceutically acceptable salt thereof or combination thereof.

Status:
Grant
Type:

Utility

Filling date:

22 Oct 2018

Issue date:

27 Jul 2021